慢性HBV感染免疫耐受期应否治疗?

Should patients in the immune tolerance stage of chronic hepatitis B virus infection be treated?

国际主要指南对慢性HBV感染免疫耐受期的定义不完全一致,但几乎所有指南均不推荐对免疫耐受期慢性乙型肝炎患者启动治疗。本文讨论了关于对HBV感染免疫耐受期患者进行抗病毒治疗的最新证据,以预防其肝硬化和肝细胞癌的发生。

Major international guidelines have not yet reached a consensus on the definition of the immune tolerance stage of chronic hepatitis B virus infection;however,almost all guidelines do not recommend starting treatment for patients in the immune tolerance stage of chronic hepatitis B.This article discusses the latest evidence for the treatment of such patients to prevent liver cirrhosis and hepatocellular carcinoma.